Joshua Rosenblat
Clinical trials sponsored by Joshua Rosenblat, explained in plain language.
-
Ketamine shows promise for stubborn bipolar depression
Disease control CompletedThis study tested whether regular ketamine infusions could help maintain relief from severe bipolar depression in people who initially responded to the treatment. Forty-one adults with treatment-resistant bipolar depression received flexible-dose ketamine infusions every 2-4 week…
Phase: PHASE2 • Sponsor: Joshua Rosenblat • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Ketamine shows promise for stubborn bipolar depression in new trial
Disease control CompletedThis study tested whether repeated low-dose ketamine infusions could help people with treatment-resistant bipolar depression. 71 participants who hadn't responded to standard medications received either ketamine or a sedative placebo over two weeks. Researchers measured changes i…
Phase: PHASE2 • Sponsor: Joshua Rosenblat • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC